Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Lysiphlebus fabarum whole genome sequencing

PROVIDER: PRJNA510896 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8357230_1.fastq.gz	Fastqsanger.gz
	SRR8357230_2.fastq.gz	Fastqsanger.gz
	SRR8357228_subreads.fastq.gz	Fastqsanger.gz
	SRR8357229_1.fastq.gz	Fastqsanger.gz
	SRR8357229_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Acetobacter fabarum DSM 19596

Project description:Acetobacter fabarum DSM 19596 genome sequencing project

| PRJDB1013 | ENA

Lysiphlebus fabarum (Hymenoptera: Braconidae: Aphidiinae) venom proteomic analysis

Project description:Venom injected at oviposition is crucial for successful reproduction in most parasitoid wasp species (Moreau & Asgari 2015; Poirié et al. 2014). The venom of the pea aphid parasitoid Aphidius ervi was analyzed previously using a combined transcriptomic and proteomic approach (Colinet et al. 2014) and we applied similar methods here to compare the venom composition in Lysiphlebus fabarum, that also used the pea aphid as host. Venom was extracted from the L. fabarum venom gland and analyzed using 1D gel electrophoresis and mass spectrometry. A total of 35 L. fabarum proteins were identified as putative venom proteins using these results combined with available transcriptomic data (Dennis et al. 2017) and the genomic data.

2020-04-24 | PXD015758 | Pride

MuSt multiomics

Project description:Multiomics of faecal samples collected from individuals in families with multiple cases of type 1 diabetes mellitus (T1DM) over 3 or 4 months. Metagenomic and metatranscriptomic sequencing and metaproteomics were carried out, as well as whole human genome sequencing. Phenotypic data is available.

2017-10-19 | MSV000081630 | MassIVE

MuSt multiomics - Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes

2016-08-22 | PXD003791 | Pride

Tandem mass spectrometry proteotyping of extremophiles sampled from high-altitude Andean lakes

Project description:The proteome of the SS13 isolate assigned to the Chromatiaceae family was assessed by shotgun proteomics using a pan-proteomics database for the genus Rheinheimera and a whole genome sequencing -derived database.

2024-05-02 | PXD044759 | Pride

Lysiphlebus fabarum

Project description:Lysiphlebus fabarum Transcriptome or Gene expression

| PRJNA290156 | ENA

Molecular analysis of clinically defined subsets of high-grade serous ovarian cancer

Project description:The diversity and heterogeneity within high-grade serous ovarian cancer (HGSC) is not well understood. Comprehensive molecular analyses were performed including high-pass whole-genome sequencing, targeted deep DNA sequencing, RNA sequencing, reverse-phase protein arrays, mass spectrometry-based proteomics and phosphoproteomics, and immune profiling on primary and metastatic sites from highly clinically annotated HGSC samples. Samples were obtained pre-treatment based on a laparoscopic triage algorithm from patients who underwent R0 tumor debulking or received neoadjuvant chemotherapy (NACT) with excellent or poor response.

2020-05-27 | PXD014980 | Pride

DNA_seq_3

Project description:Whole Genome Sequencing

| OEX00001927 | NODE

Whole genome sequencing

Project description:Whole genome sequencing

| OEX00001931 | NODE